SBOT Insider Trading Activity and SEC Form 4 Filings
SBOT insider trading summary
No open-market insider purchases or sales of Stellar Biotechnologies, Inc. (SBOT) have been reported on SEC Form 4 in the past 12 months.
Latest SBOT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 6, 2019 | Frank R. Oakes | President & CEO | Sell | $5K (4,000 @ $1.25) |
| Oct 12, 2018 | Daniel E. Morse | Insider | Sell | $9K (7,047 @ $1.31) |
| Oct 12, 2018 | Frank R. Oakes | President & CEO | Sell | $4K (3,000 @ $1.31) |
| Mar 29, 2018 | Daniel E. Morse | Director | Sell | $4K (4,366 @ $0.81) |
| Mar 12, 2018 | Daniel E. Morse | Director | Sell | $3K (3,500 @ $0.80) |
| Mar 9, 2018 | Daniel E. Morse | Director | Sell | $6K (7,000 @ $0.81) |
| Feb 28, 2018 | Daniel E. Morse | Director | Sell | $6K (7,000 @ $0.79) |
| Feb 26, 2018 | Daniel E. Morse | Director | Sell | $6K (7,000 @ $0.79) |
| Feb 22, 2018 | Daniel E. Morse | Director | Sell | $6K (7,800 @ $0.78) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.